Complete pre-clinical studies for UNI-494
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 12 Nov 2021
- Due
- 30 Jun 2022
- Delivered
- March 2023
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Planned completion of pre-clinical studies with UNI-494 in the first half of 2022”
What we found
Evidence strength A What the grades mean
The company indicated in August 2022 that toxicity studies were still ongoing, and later confirmed in March 2023 that non-clinical safety assessment studies were completed.
-
A Unicycive Therapeutics, Inc. 8-K filed 2022-08-15
“Repeat dose toxicity studies in two species are on track to be completed in the third quarter.” ✓ confirmed on the page
-
A Unicycive Therapeutics, Inc. 10-K filed 2023-03-31
“We have completed all non-clinical safety assessment studies required for regulatory filing” ✓ confirmed on the page
Market reaction: the shares moved -3.0% against the S&P 500 over the three sessions around the disclosure (12 Aug 2022 to 17 Aug 2022). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- pre-clinical studies with UNI-494
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Not met”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Unicycive Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-UNCY-002763 · Corrections policy